Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Judith Regensteiner

Concepts (530)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intermittent Claudication
46
2022
118
5.110
 Why?
Diabetes Mellitus, Type 2
54
2024
2531
4.490
 Why?
Sex Characteristics
18
2024
762
3.430
 Why?
Peripheral Arterial Disease
24
2022
475
3.330
 Why?
Exercise
47
2024
2057
3.240
 Why?
Exercise Therapy
31
2022
443
2.930
 Why?
Peripheral Vascular Diseases
25
2011
103
2.560
 Why?
Sex Factors
20
2024
2071
2.280
 Why?
Oxygen Consumption
33
2021
696
2.120
 Why?
Cardiovascular Diseases
23
2024
2111
1.970
 Why?
Walking
23
2022
529
1.930
 Why?
Diabetes Mellitus
18
2024
1040
1.890
 Why?
Women's Health
10
2024
372
1.770
 Why?
Biomedical Research
8
2024
692
1.470
 Why?
Exercise Test
38
2019
625
1.420
 Why?
Cardiology
6
2023
274
1.210
 Why?
Exercise Tolerance
15
2024
279
1.170
 Why?
American Heart Association
10
2019
306
1.140
 Why?
Quality of Life
18
2019
2892
1.090
 Why?
Leg
13
2021
236
1.040
 Why?
Research Personnel
5
2024
173
1.040
 Why?
Humans
184
2024
137585
0.930
 Why?
Mentoring
3
2022
149
0.880
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
77
0.880
 Why?
United States Food and Drug Administration
1
2024
208
0.840
 Why?
Diabetic Angiopathies
6
2017
259
0.840
 Why?
Vascular Stiffness
3
2023
494
0.820
 Why?
Female
106
2024
73304
0.800
 Why?
Muscle, Skeletal
14
2024
1724
0.790
 Why?
Male
101
2024
67762
0.770
 Why?
Community Health Services
2
2015
227
0.770
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2024
445
0.770
 Why?
Cardiovascular System
5
2023
137
0.770
 Why?
Diabetic Cardiomyopathies
3
2016
36
0.760
 Why?
Education, Medical
3
2020
266
0.750
 Why?
Periodicals as Topic
1
2024
211
0.740
 Why?
Insulin Resistance
12
2024
1208
0.690
 Why?
Lower Extremity
9
2019
427
0.680
 Why?
Arterial Occlusive Diseases
7
2015
83
0.660
 Why?
Interdisciplinary Research
1
2020
27
0.660
 Why?
Cardiorespiratory Fitness
2
2019
55
0.630
 Why?
Aged
57
2024
23961
0.630
 Why?
Middle Aged
73
2024
33479
0.620
 Why?
Endothelium, Vascular
6
2021
927
0.620
 Why?
Sitagliptin Phosphate
1
2019
33
0.620
 Why?
Obesity
19
2023
2992
0.620
 Why?
Diastole
1
2019
149
0.600
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
47
0.600
 Why?
Surveys and Questionnaires
23
2018
5778
0.580
 Why?
Physical Fitness
9
2016
209
0.570
 Why?
Gender Identity
1
2019
124
0.570
 Why?
United States
37
2024
14841
0.570
 Why?
Hypoglycemic Agents
9
2021
1291
0.550
 Why?
Metabolomics
2
2020
678
0.550
 Why?
Health Status
4
2020
792
0.540
 Why?
Brachial Artery
6
2015
205
0.540
 Why?
Mitochondria, Muscle
4
2024
116
0.530
 Why?
Physical Exertion
7
2009
215
0.530
 Why?
Hypertension
6
2022
1295
0.530
 Why?
Venoms
1
2016
29
0.520
 Why?
Blood Pressure
12
2021
1786
0.510
 Why?
Curriculum
2
2020
992
0.510
 Why?
Vasodilator Agents
4
2010
331
0.510
 Why?
Biomarkers
6
2024
4149
0.480
 Why?
Cardiac Rehabilitation
3
2019
37
0.450
 Why?
Research Design
5
2024
1139
0.440
 Why?
Life Style
9
2018
490
0.440
 Why?
National Institutes of Health (U.S.)
4
2023
128
0.440
 Why?
Arteriosclerosis
5
2002
88
0.430
 Why?
Sleep
1
2020
755
0.420
 Why?
Physicians
5
2024
910
0.410
 Why?
Ventricular Dysfunction, Left
1
2016
382
0.410
 Why?
Faculty, Medical
6
2024
283
0.410
 Why?
Home Care Services
4
2019
257
0.400
 Why?
Diabetes Mellitus, Type 1
9
2024
3715
0.390
 Why?
Microcirculation
4
2017
149
0.390
 Why?
Risk Factors
29
2022
10388
0.390
 Why?
Advisory Committees
5
2019
219
0.380
 Why?
Mentors
4
2022
202
0.380
 Why?
Blood Flow Velocity
4
2009
413
0.370
 Why?
Longevity
3
2024
165
0.370
 Why?
Adult
40
2024
37929
0.340
 Why?
Peptides
1
2016
985
0.340
 Why?
Disability Evaluation
2
2011
290
0.340
 Why?
Ankle
3
2008
60
0.340
 Why?
Weight Loss
6
2016
787
0.330
 Why?
Treatment Outcome
24
2022
10811
0.330
 Why?
Gait
2
2006
296
0.320
 Why?
Regional Blood Flow
11
2020
474
0.310
 Why?
Tetrazoles
3
2006
41
0.310
 Why?
Cardiac Output, Low
1
2009
66
0.300
 Why?
Physical Endurance
3
2011
275
0.300
 Why?
Thiazolidinediones
3
2010
137
0.300
 Why?
Double-Blind Method
8
2019
1993
0.290
 Why?
Oxygen
4
2018
931
0.290
 Why?
Research Support as Topic
2
2020
119
0.290
 Why?
Recovery of Function
9
2019
653
0.290
 Why?
Cost of Illness
3
2018
308
0.280
 Why?
Fear
1
2011
338
0.280
 Why?
Oxidative Phosphorylation
2
2019
193
0.280
 Why?
Follow-Up Studies
9
2024
5131
0.270
 Why?
Glucagon-Like Peptide 1
2
2020
135
0.270
 Why?
Hematologic Agents
1
2006
2
0.270
 Why?
Perception
1
2009
359
0.260
 Why?
Activities of Daily Living
5
2021
413
0.260
 Why?
Blood Glucose
10
2024
2186
0.260
 Why?
Medicare
2
2022
773
0.260
 Why?
Stents
6
2015
527
0.250
 Why?
Caregivers
3
2024
877
0.250
 Why?
Disease Management
4
2017
628
0.240
 Why?
Motor Activity
5
2012
718
0.240
 Why?
Vascular Diseases
4
2000
243
0.240
 Why?
Foundations
2
2018
28
0.240
 Why?
Vascular Surgical Procedures
5
2009
303
0.230
 Why?
Pharmacovigilance
1
2024
23
0.230
 Why?
Feasibility Studies
2
2022
956
0.230
 Why?
Interdisciplinary Studies
2
2017
27
0.230
 Why?
Societies, Medical
3
2017
820
0.230
 Why?
Echocardiography
4
2018
642
0.230
 Why?
Troponin
1
2024
50
0.220
 Why?
Troponin T
1
2024
65
0.220
 Why?
Vasodilation
3
2015
499
0.220
 Why?
Respiration
3
1990
199
0.220
 Why?
Fibrinolysis
2
2003
146
0.220
 Why?
Heart Rate
6
2015
822
0.210
 Why?
Insulin
5
2020
2409
0.210
 Why?
Troponin I
1
2024
81
0.210
 Why?
Overweight
6
2023
558
0.210
 Why?
Chest Pain
1
2024
91
0.210
 Why?
Medroxyprogesterone
4
1991
11
0.210
 Why?
Kinetics
5
2015
1670
0.210
 Why?
Pulse Wave Analysis
3
2023
272
0.210
 Why?
Lung Diseases
3
2019
767
0.200
 Why?
Muscles
7
1994
326
0.200
 Why?
Iliac Artery
2
2014
55
0.200
 Why?
Minority Groups
2
2022
266
0.200
 Why?
Polyhydroxyethyl Methacrylate
1
2002
10
0.200
 Why?
Financing, Organized
2
2020
35
0.200
 Why?
Financial Management
1
2022
18
0.200
 Why?
Phosphodiesterase Inhibitors
1
2002
89
0.190
 Why?
Glucose Intolerance
1
2024
146
0.190
 Why?
Predictive Value of Tests
5
2017
2031
0.190
 Why?
Vitamin E
1
2003
124
0.190
 Why?
Orthopedics
1
2024
144
0.190
 Why?
Practice Guidelines as Topic
4
2019
1587
0.190
 Why?
Endovascular Procedures
2
2018
312
0.190
 Why?
Estrogens, Conjugated (USP)
3
1991
49
0.180
 Why?
Academic Medical Centers
3
2020
512
0.180
 Why?
Congresses as Topic
2
2020
233
0.180
 Why?
Ascorbic Acid
1
2003
177
0.180
 Why?
Organizational Innovation
2
2020
140
0.180
 Why?
Placebos
3
2019
199
0.180
 Why?
Arginine
1
2003
271
0.180
 Why?
Adiponectin
2
2016
244
0.180
 Why?
Interdisciplinary Communication
2
2020
191
0.180
 Why?
Severity of Illness Index
4
2009
2828
0.170
 Why?
Qualitative Research
3
2024
1386
0.170
 Why?
Echocardiography, Doppler
3
2016
108
0.170
 Why?
Sulfonylurea Compounds
2
2019
48
0.170
 Why?
Sex Distribution
2
2020
375
0.170
 Why?
Neovascularization, Physiologic
2
2012
179
0.170
 Why?
Precision Medicine
2
2024
429
0.170
 Why?
Cardiovascular Agents
2
2014
159
0.160
 Why?
Patient Compliance
4
2015
581
0.160
 Why?
Time Factors
11
2018
6828
0.160
 Why?
Forearm
2
2015
119
0.160
 Why?
Hemodynamics
6
2009
1113
0.160
 Why?
Arteries
3
2016
269
0.160
 Why?
Clinical Trials as Topic
6
2019
1050
0.160
 Why?
Case-Control Studies
7
2024
3556
0.160
 Why?
Randomized Controlled Trials as Topic
7
2006
1477
0.150
 Why?
Pediatric Obesity
2
2017
601
0.150
 Why?
Body Composition
5
2014
684
0.150
 Why?
Telerehabilitation
1
2019
37
0.150
 Why?
Body Mass Index
9
2017
2389
0.150
 Why?
Adolescent
12
2022
21513
0.150
 Why?
Cross-Sectional Studies
8
2014
5472
0.150
 Why?
Cause of Death
1
2020
434
0.140
 Why?
Women's Rights
1
2017
4
0.140
 Why?
Diabetes Complications
4
2010
227
0.140
 Why?
Leadership
2
2020
388
0.140
 Why?
Burnout, Professional
1
2024
442
0.140
 Why?
Pentoxifylline
3
2006
25
0.140
 Why?
Magnetic Resonance Spectroscopy
2
2024
611
0.140
 Why?
Health Status Indicators
4
2015
171
0.140
 Why?
Sexism
1
2018
61
0.140
 Why?
Program Development
1
2019
364
0.140
 Why?
Aged, 80 and over
9
2012
7635
0.140
 Why?
Death, Sudden, Cardiac
1
2018
185
0.140
 Why?
Interviews as Topic
4
2024
786
0.140
 Why?
Resistance Training
1
2020
164
0.140
 Why?
Heart Diseases
2
2019
346
0.130
 Why?
Circadian Rhythm
2
2020
468
0.130
 Why?
Colorado
9
2017
4565
0.130
 Why?
Ankle Brachial Index
2
2014
37
0.130
 Why?
Capillaries
3
2012
108
0.130
 Why?
Microvessels
1
2017
88
0.130
 Why?
Glucose Tolerance Test
4
2024
366
0.120
 Why?
Faculty
1
2017
147
0.120
 Why?
Reference Values
4
2007
816
0.120
 Why?
Ischemia
1
2019
409
0.120
 Why?
Blood Vessels
1
2017
187
0.120
 Why?
Needs Assessment
1
2018
376
0.120
 Why?
Leptin
1
2017
236
0.120
 Why?
Plethysmography
3
2011
106
0.120
 Why?
Intention to Treat Analysis
1
2015
73
0.120
 Why?
Adiposity
2
2017
518
0.120
 Why?
Program Evaluation
2
2020
898
0.110
 Why?
Health Status Disparities
1
2018
289
0.110
 Why?
Myocardium
1
2020
1002
0.110
 Why?
Ventricular Function
1
2015
61
0.110
 Why?
Cardiac Output
1
2015
165
0.110
 Why?
Physical Education and Training
1
1994
76
0.110
 Why?
Pilot Projects
2
2015
1710
0.110
 Why?
Endothelium
1
2015
123
0.110
 Why?
Arterial Pressure
1
2015
126
0.110
 Why?
Oxidative Stress
1
2021
1317
0.110
 Why?
Healthy Volunteers
1
2015
199
0.110
 Why?
Peripheral Nervous System Diseases
1
1995
128
0.110
 Why?
Patient Selection
4
2019
696
0.110
 Why?
Hyperlipidemias
3
2004
120
0.110
 Why?
Hypoxia
3
1990
1112
0.100
 Why?
Health Care Costs
2
2014
398
0.100
 Why?
Diagnostic Self Evaluation
1
2013
23
0.100
 Why?
Angioplasty
2
2009
47
0.100
 Why?
Aortic Diseases
1
2014
119
0.100
 Why?
Menopause
3
1991
320
0.100
 Why?
Reaction Time
1
2015
412
0.100
 Why?
Diet, Reducing
1
2013
89
0.100
 Why?
Carnitine
5
2001
84
0.100
 Why?
Ventricular Function, Left
1
2016
534
0.100
 Why?
Diabetic Nephropathies
2
2014
294
0.090
 Why?
Students, Medical
1
2017
348
0.090
 Why?
Capacity Building
1
2012
63
0.090
 Why?
Premenopause
2
2003
131
0.090
 Why?
Retrospective Studies
4
2024
15657
0.090
 Why?
Counseling
1
2015
391
0.090
 Why?
Smoking
6
2010
1627
0.090
 Why?
Myocardial Revascularization
1
2011
73
0.090
 Why?
Kidney
2
2021
1468
0.090
 Why?
Clinical Protocols
1
1993
271
0.090
 Why?
Health Promotion
1
2017
741
0.090
 Why?
Heart Ventricles
1
2016
788
0.090
 Why?
Linear Models
2
2014
849
0.090
 Why?
Research Report
1
2011
83
0.090
 Why?
Benchmarking
1
2012
186
0.090
 Why?
Sickness Impact Profile
1
2011
56
0.090
 Why?
Fatty Acids, Nonesterified
2
2009
159
0.090
 Why?
Hemoglobins
2
2017
353
0.090
 Why?
Hyperemia
1
2011
49
0.090
 Why?
Comorbidity
4
2021
1622
0.090
 Why?
Self Concept
1
2012
253
0.090
 Why?
Coronary Disease
4
2004
385
0.080
 Why?
Consensus
3
2019
683
0.080
 Why?
Niacin
1
2010
17
0.080
 Why?
Affect
1
2012
292
0.080
 Why?
Lovastatin
1
2010
37
0.080
 Why?
Atherosclerosis
2
2011
415
0.080
 Why?
Hypertrophy, Left Ventricular
2
2009
131
0.080
 Why?
Young Adult
6
2024
13209
0.080
 Why?
C-Reactive Protein
2
2009
410
0.080
 Why?
Platelet Aggregation Inhibitors
3
2002
463
0.080
 Why?
Body Fat Distribution
1
2009
49
0.080
 Why?
Gonadal Steroid Hormones
1
1990
140
0.080
 Why?
Heart Function Tests
1
2009
59
0.080
 Why?
Vascular Endothelial Growth Factor A
1
2012
545
0.080
 Why?
Hyperinsulinism
2
2010
121
0.080
 Why?
Pulmonary Wedge Pressure
1
2009
69
0.080
 Why?
Aorta
1
2011
417
0.080
 Why?
Thinness
1
2009
91
0.080
 Why?
Hospitalization
1
2018
2199
0.070
 Why?
Psychometrics
1
2012
720
0.070
 Why?
Heart Failure
3
2018
2236
0.070
 Why?
Analysis of Variance
4
2012
1316
0.070
 Why?
Fasting
2
2005
281
0.070
 Why?
Age Factors
4
2021
3295
0.070
 Why?
Puberty
1
2009
146
0.070
 Why?
Perfusion
1
2009
213
0.070
 Why?
Angina Pectoris
1
2008
65
0.070
 Why?
Cost-Benefit Analysis
4
2014
591
0.070
 Why?
Myoglobin
1
2007
13
0.070
 Why?
Leisure Activities
2
2006
33
0.070
 Why?
Mitochondria
1
2014
948
0.070
 Why?
Inflammation
3
2009
2837
0.070
 Why?
Aging
1
2018
1864
0.070
 Why?
Awareness
1
2008
103
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2008
1329
0.060
 Why?
Prospective Studies
8
2019
7604
0.060
 Why?
Prevalence
3
2019
2734
0.060
 Why?
Regression Analysis
5
1998
1024
0.060
 Why?
Dyspnea
1
2008
254
0.060
 Why?
Glycation End Products, Advanced
1
2006
82
0.060
 Why?
Chronic Disease
2
2023
1793
0.060
 Why?
Blood Viscosity
2
1995
17
0.060
 Why?
Pulmonary Circulation
1
2007
429
0.060
 Why?
Metformin
2
2010
331
0.060
 Why?
Neoplasms
2
2010
2671
0.060
 Why?
Glucose Clamp Technique
1
2005
195
0.060
 Why?
Hematocrit
2
1995
96
0.060
 Why?
Multicenter Studies as Topic
2
2004
310
0.060
 Why?
Sulfonic Acids
1
2004
13
0.060
 Why?
Interleukin-6
1
2009
778
0.060
 Why?
Guilt
1
2024
11
0.060
 Why?
Animals
5
2018
36940
0.060
 Why?
Lipids
1
2009
672
0.060
 Why?
Nutrition Surveys
1
2006
266
0.060
 Why?
Population Dynamics
1
1985
151
0.060
 Why?
Work-Life Balance
1
2024
22
0.060
 Why?
Acetates
1
2004
99
0.050
 Why?
Estrogens
2
2010
367
0.050
 Why?
Health Maintenance Organizations
1
2004
108
0.050
 Why?
Cohort Studies
3
2016
5742
0.050
 Why?
Incidence
3
2019
2804
0.050
 Why?
Dietary Carbohydrates
1
2004
155
0.050
 Why?
Biopsy
3
2012
1129
0.050
 Why?
Body Weight
2
2006
985
0.050
 Why?
Mitochondrial Diseases
1
2024
91
0.050
 Why?
Physicians, Women
1
2024
83
0.050
 Why?
Intracranial Arterial Diseases
1
2002
8
0.050
 Why?
Genetic Vectors
1
2004
319
0.050
 Why?
Dietary Fats
1
2004
304
0.050
 Why?
Child
5
2017
21935
0.050
 Why?
Neovascularization, Pathologic
1
2004
301
0.050
 Why?
Serum Globulins
1
2002
5
0.050
 Why?
Glycolysis
1
2024
321
0.050
 Why?
Musculoskeletal Diseases
1
2003
78
0.050
 Why?
Genetic Therapy
1
2004
297
0.050
 Why?
Prognosis
2
2010
4030
0.050
 Why?
Lung
1
2015
4060
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2002
86
0.050
 Why?
Pelvis
1
2002
102
0.050
 Why?
Psychomotor Performance
1
2004
309
0.050
 Why?
Single-Blind Method
2
2013
282
0.050
 Why?
Ambulatory Care
2
2014
546
0.050
 Why?
Fibroblast Growth Factor 2
1
2001
87
0.050
 Why?
Proteinuria
1
2001
97
0.040
 Why?
Homocysteine
1
2002
156
0.040
 Why?
Alcohol Drinking
2
2010
828
0.040
 Why?
Adipose Tissue
1
2005
635
0.040
 Why?
Diet
2
2010
1278
0.040
 Why?
Physical Examination
1
2002
241
0.040
 Why?
Patient Satisfaction
2
2002
660
0.040
 Why?
Fibrinogen
1
2002
168
0.040
 Why?
Enzyme Inhibitors
1
2004
840
0.040
 Why?
Aorta, Thoracic
1
2023
267
0.040
 Why?
Meta-Analysis as Topic
1
2002
186
0.040
 Why?
Cardiovascular Surgical Procedures
1
2000
30
0.040
 Why?
Multivariate Analysis
3
2014
1509
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
201
0.040
 Why?
Altitude
1
1985
488
0.040
 Why?
Administration, Oral
1
2003
816
0.040
 Why?
Cholesterol, LDL
2
2014
365
0.040
 Why?
Tissue Plasminogen Activator
1
2002
224
0.040
 Why?
Myocardial Ischemia
1
2002
263
0.040
 Why?
Medroxyprogesterone Acetate
2
1990
36
0.040
 Why?
Carrier Proteins
1
2004
771
0.040
 Why?
Internal Medicine
1
2002
265
0.040
 Why?
Specialties, Surgical
1
2000
75
0.040
 Why?
Organization and Administration
1
2019
12
0.040
 Why?
Pregnancy
3
2020
6763
0.040
 Why?
Femoral Artery
2
2011
179
0.040
 Why?
Sports Medicine
2
2010
112
0.040
 Why?
Rural Population
2
1995
563
0.040
 Why?
Risk Adjustment
1
2019
78
0.040
 Why?
Asia
1
2018
71
0.040
 Why?
Densitometry
1
1998
36
0.040
 Why?
Lactic Acid
2
1998
305
0.040
 Why?
Apoptosis
1
2007
2553
0.040
 Why?
Patient Outcome Assessment
1
2019
131
0.040
 Why?
Hypercapnia
2
1989
53
0.040
 Why?
Social Stigma
1
2020
137
0.040
 Why?
Walking Speed
1
2018
46
0.040
 Why?
Coronary Vessels
1
2020
248
0.040
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2001
350
0.040
 Why?
Cell Respiration
1
2018
103
0.040
 Why?
Autonomic Nervous System
1
1998
75
0.040
 Why?
Secondary Prevention
1
2019
233
0.040
 Why?
Public Health
1
2023
588
0.040
 Why?
Walk Test
1
2018
76
0.030
 Why?
Hand Strength
1
2018
123
0.030
 Why?
Neural Conduction
2
1995
86
0.030
 Why?
Smoking Cessation
1
2002
442
0.030
 Why?
Capillary Resistance
1
2017
5
0.030
 Why?
Depression
1
2007
1397
0.030
 Why?
Pragmatic Clinical Trials as Topic
1
2017
65
0.030
 Why?
Drug Therapy, Combination
2
2010
1066
0.030
 Why?
Betacoronavirus
1
2020
270
0.030
 Why?
Career Choice
1
2019
219
0.030
 Why?
Acute Disease
1
2020
1007
0.030
 Why?
Oxyhemoglobins
1
2017
23
0.030
 Why?
Weight Reduction Programs
1
2018
117
0.030
 Why?
Caloric Restriction
1
2018
124
0.030
 Why?
Family Practice
1
2001
464
0.030
 Why?
Reproducibility of Results
2
2013
3284
0.030
 Why?
Spectroscopy, Near-Infrared
1
2017
59
0.030
 Why?
Canada
1
2018
418
0.030
 Why?
Bicycling
1
2017
114
0.030
 Why?
Heart
1
2020
655
0.030
 Why?
Forecasting
2
2000
389
0.030
 Why?
Sensitivity and Specificity
2
2013
1946
0.030
 Why?
Social Support
1
2020
618
0.030
 Why?
Vascular Resistance
1
2017
375
0.030
 Why?
Stroke Volume
1
2018
612
0.030
 Why?
Matched-Pair Analysis
1
1995
39
0.030
 Why?
Pneumonia, Viral
1
2020
373
0.030
 Why?
Coronavirus Infections
1
2020
364
0.030
 Why?
Absorptiometry, Photon
1
2016
259
0.030
 Why?
Energy Intake
3
2006
485
0.030
 Why?
Risk
1
2017
912
0.030
 Why?
Electrophysiology
1
1995
217
0.030
 Why?
Cystatin C
1
2014
65
0.030
 Why?
Vascular Patency
1
2014
106
0.030
 Why?
Quality-Adjusted Life Years
1
2014
113
0.030
 Why?
Models, Economic
1
2014
58
0.030
 Why?
Life Expectancy
1
2014
69
0.030
 Why?
Patient Education as Topic
1
2019
766
0.030
 Why?
Phosphorus
1
2014
97
0.030
 Why?
Stress, Mechanical
1
2016
485
0.030
 Why?
Hospital Costs
1
2014
117
0.030
 Why?
Constriction, Pathologic
1
2014
245
0.030
 Why?
Databases, Factual
2
2011
1357
0.030
 Why?
Drug Costs
1
2014
106
0.030
 Why?
Health Behavior
1
2019
762
0.030
 Why?
Cyclic AMP Response Element-Binding Protein
1
2014
145
0.030
 Why?
Nitric Oxide Synthase Type III
1
2014
204
0.030
 Why?
Health Education
1
2016
341
0.030
 Why?
Collateral Circulation
2
2003
19
0.030
 Why?
Carotid Stenosis
1
2014
91
0.030
 Why?
Creatinine
1
2014
499
0.020
 Why?
Biomechanical Phenomena
1
2016
810
0.020
 Why?
Administrative Personnel
1
2012
29
0.020
 Why?
Blood Vessel Prosthesis
1
2013
127
0.020
 Why?
Statistics as Topic
1
2013
307
0.020
 Why?
Waist Circumference
1
2012
143
0.020
 Why?
Evidence-Based Medicine
1
2016
740
0.020
 Why?
Internship and Residency
1
2002
1147
0.020
 Why?
Treatment Failure
1
2013
356
0.020
 Why?
Health Planning
1
1992
47
0.020
 Why?
North Carolina
1
2012
110
0.020
 Why?
Pandemics
1
2020
1639
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
71
0.020
 Why?
Muscle Strength
1
2014
317
0.020
 Why?
Muscle Contraction
1
2014
424
0.020
 Why?
Popliteal Artery
1
2011
59
0.020
 Why?
Cerebrovascular Disorders
1
1992
96
0.020
 Why?
Estrone
1
1991
37
0.020
 Why?
Radioimmunoassay
1
1991
173
0.020
 Why?
Behavior Therapy
1
2014
264
0.020
 Why?
Kaplan-Meier Estimate
1
2013
889
0.020
 Why?
Glomerular Filtration Rate
1
2014
746
0.020
 Why?
Follicular Phase
1
1990
39
0.020
 Why?
C-Peptide
1
1991
163
0.020
 Why?
Metabolism
1
1990
42
0.020
 Why?
Luteal Phase
1
1990
45
0.020
 Why?
Incretins
1
2010
22
0.020
 Why?
Receptor, IGF Type 1
1
2010
65
0.020
 Why?
Receptor, Insulin
1
2010
105
0.020
 Why?
Actigraphy
1
2010
110
0.020
 Why?
Acetylcarnitine
1
1989
5
0.020
 Why?
Adaptation, Physiological
1
2014
553
0.020
 Why?
Health Services Research
1
2012
404
0.020
 Why?
Percutaneous Coronary Intervention
1
2015
480
0.020
 Why?
Progesterone
1
1991
254
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
852
0.020
 Why?
Delayed-Action Preparations
1
2010
181
0.020
 Why?
Risk Assessment
2
2009
3457
0.020
 Why?
Attitude of Health Personnel
1
2017
1171
0.020
 Why?
Respiration Disorders
1
1989
77
0.020
 Why?
Energy Metabolism
3
2006
922
0.020
 Why?
Partial Pressure
1
1988
30
0.020
 Why?
Tidal Volume
1
1988
86
0.020
 Why?
Estradiol
1
1991
521
0.020
 Why?
Drug Interactions
1
1989
410
0.020
 Why?
Pain
1
1993
756
0.020
 Why?
Ankle Joint
1
2008
114
0.020
 Why?
Risk Reduction Behavior
1
2009
220
0.020
 Why?
Fluoroquinolones
1
2007
51
0.020
 Why?
Caspase 3
1
2007
246
0.020
 Why?
Hyperglycemia
1
2010
347
0.020
 Why?
Models, Cardiovascular
1
2007
198
0.020
 Why?
Longitudinal Studies
1
2014
2844
0.020
 Why?
Testosterone
1
2010
409
0.020
 Why?
Receptor for Advanced Glycation End Products
1
2006
33
0.020
 Why?
Enzyme Activation
1
2007
810
0.020
 Why?
Income
1
2007
202
0.020
 Why?
Carbon Dioxide
1
1988
267
0.020
 Why?
Sleep Wake Disorders
1
1989
286
0.010
 Why?
Sterol O-Acyltransferase
1
2004
5
0.010
 Why?
Receptors, Immunologic
1
2006
216
0.010
 Why?
Acetamides
1
2004
36
0.010
 Why?
Case Management
1
2004
66
0.010
 Why?
Age Distribution
1
2004
392
0.010
 Why?
Cell Adhesion Molecules
1
2004
181
0.010
 Why?
Gene Transfer Techniques
1
2004
170
0.010
 Why?
Calcium-Binding Proteins
1
2004
218
0.010
 Why?
Cognition Disorders
1
2007
496
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
382
0.010
 Why?
Magnetic Resonance Imaging
1
2014
3566
0.010
 Why?
Cytokines
1
2010
2085
0.010
 Why?
Endpoint Determination
1
2001
77
0.010
 Why?
Lactates
2
1992
85
0.010
 Why?
Ultrasonography, Doppler
1
2001
124
0.010
 Why?
Sulfonamides
1
2004
513
0.010
 Why?
Algorithms
1
2008
1704
0.010
 Why?
Attitude
1
2002
259
0.010
 Why?
Wound Healing
1
2003
331
0.010
 Why?
World Health Organization
1
2000
123
0.010
 Why?
Costs and Cost Analysis
1
2000
213
0.010
 Why?
Artificial Limbs
1
2003
200
0.010
 Why?
Logistic Models
1
2004
2074
0.010
 Why?
Models, Biological
1
2006
1783
0.010
 Why?
Interpersonal Relations
1
2002
397
0.010
 Why?
Indians, North American
1
2004
643
0.010
 Why?
Socioeconomic Factors
1
2002
1289
0.010
 Why?
Diabetic Neuropathies
1
1998
94
0.010
 Why?
Models, Theoretical
1
2000
578
0.010
 Why?
Diabetic Retinopathy
1
1998
189
0.010
 Why?
Muscle Fibers, Skeletal
1
1996
218
0.010
 Why?
Rehabilitation
1
1992
19
0.010
 Why?
Cholesterol, HDL
1
1991
203
0.010
 Why?
Hydroxybutyrates
1
1989
14
0.010
 Why?
Electromyography
1
1992
400
0.010
 Why?
3-Hydroxybutyric Acid
1
1989
17
0.010
 Why?
Blood Gas Analysis
1
1989
74
0.000
 Why?
Nervous System Diseases
1
1992
266
0.000
 Why?
Ultrasonics
1
1989
49
0.000
 Why?
Action Potentials
1
1992
493
0.000
 Why?
Sleep Apnea Syndromes
1
1989
88
0.000
 Why?
Drug Combinations
1
1989
343
0.000
 Why?
Mice
1
1989
17787
0.000
 Why?
Regensteiner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (530) concept(s)
_
Co-Authors Expand Description
See all (51) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)